A Phase 2 Trial of Regorafenib As a Single Agent in Patients with Chemotherapy-Refractory, Advanced, and Metastatic Biliary Tract Adenocarcinoma
CANCER（2019）
关键词
biliary tract cancer (BTC),chemotherapy refractory,cholangiocarcinoma,gallbladder cancer,regorafenib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要